ArticleAmerican journal of translational research2023

EGT022, an RGD-containing recombinant disintegrin, inhibits the VEGF-induced angiogenic process by targeting integrin β3 in endothelial cells.

Bong-Kyu Kim et al.PubMed ↗Full text ↗

No numbers read from the abstract.